Madrigal Pharmaceuticals, Inc. (BIT:1MDGL)

Italy flag Italy · Delayed Price · Currency is EUR
291.90
0.00 (0.00%)
At close: Aug 8, 2025, 5:30 PM CET
Market Cap6.85B
Revenue (ttm)438.99M
Net Income (ttm)-240.04M
Shares Outn/a
EPS (ttm)-10.91
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Average Volume1
Open291.90
Previous Close291.90
Day's Range291.90 - 291.90
52-Week Range259.50 - 301.10
Betan/a
RSI94.98
Earnings DateAug 5, 2025

About Ligand Pharmaceuticals

Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States. It offers Rezdiffra, a liver-directed thyroid hormone receptor beta agonist for treating MASH. The company is headquartered in West Conshohocken, Pennsylvania. [Read more]

Industry Pharmaceutical Preparations
CEO William Sibold
Employees 528
Stock Exchange Borsa Italiana
Ticker Symbol 1MDGL
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.